AIDS Research and Human Retroviruses

Titel Veröffentlichungsdatum Sprache Zitate
Comparison of HIV Type 1 Incidence Observed during Longitudinal Follow-Up with Incidence Estimated by Cross-Sectional Analysis Using the BED Capture Enzyme Immunoassay2006/10/01English104
Quantitation of Target Molecules from Polymerase Chain Reaction-Based Limiting Dilution Assays1997/06/10English104
Inhibition of HIV Activation in Latently Infected Cells by Flavonoid Compounds1996/01/01English103
A Sensitive Reporter Cell Line for HIV-1tatActivity, HIV-1 Inhibitors, and T Cell Activation Effects1994/03/01English103
CD25+Regulatory T Cells Isolated from HIV-Infected Individuals Suppress The Cytolytic And Nonlytic Antiviral Activity of HIV-specific CD8+T Cells in Vitro2007/03/01English102
Intracellular Glutathione Levels in T Cell Subsets Decrease in HIV-Infected Individuals1992/02/01English102
Cardiac Involvement in the Acquired Immunodeficiency Syndrome: A Multicenter Clinical-Pathological Study1998/08/10English102
Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection2004/11/01English102
Lopinavir/Ritonavir Combined with Raltegravir or Tenofovir/Emtricitabine in Antiretroviral-Naive Subjects: 96-Week Results of the PROGRESS Study2013/02/01English101
Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNA2001/02/10English100
Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development2003/02/01English99
Stimulation of Glutathione Peroxidase Activity Decreases HIV Type 1 Activation after Oxidative Stress1994/11/01English99
Identification of Human T Cell Lymphotropic Virus Type IIa Infection in the Kayapo, an Indigenous Population of Brazil1995/07/01English99
The θ-Defensin, Retrocyclin, Inhibits HIV-1 Entry2003/10/01English99
Lymphoid Follicles Are Sites of Heightened Human Immunodeficiency Virus Type 1 (HIV-1) Replication and Reduced Antiretroviral Effector Mechanisms2005/05/01English98
Comparative Performance of High-Density Oligonucleotide Sequencing and Dideoxynucleotide Sequencing of HIV Type 1polfrom Clinical Samples1998/07/01English97
A New Perspective on V3 Phenotype Prediction2003/02/01English95
Priming of Strong, Broad, and Long-Lived HIV Type 1 p55gag-Specific CD8+Cytotoxic T Cells after Administration of a Virus-Like Particle Vaccine in Rhesus Macaques2000/02/10English94
Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocyte Activity Is Inversely Correlated with HIV Type 1 Viral Load in HIV Type 1-Infected Long-Term Survivors1999/09/01English93
Sustained Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in SIV-Infected Macaques Correlates with Delayed Progression to AIDS2002/11/01English92
Polymorphism of HIV Type 1 Gag p7/p1 and p1/p6 Cleavage Sites: Clinical Significance and Implications for Resistance to Protease Inhibitors2000/09/01English92
Targeting NF-κB Signaling with Protein Kinase C Agonists As an Emerging Strategy for Combating HIV Latency2015/01/01English92
IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines2010/04/01English91
A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine1994/11/01English91
Outcome of Immunization of Cynomolgus Monkeys with Recombinant Semliki Forest Virus Encoding Human Immunodeficiency Virus Type 1 Envelope Protein and Challenge with a High Dose of SHIV-4 Virus1997/11/20English91
Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern Africa2011/01/01English91
Anti-GP 120 Antibodies from HIV Seropositive Individuals Mediate Broadly Reactive Anti-HIV ADCC1987/01/01English90
Paucity of Antigen-Specific IgA Responses in Sera and External Secretions of HIV-Type 1-Infected Individuals2004/09/01English90
Position Paper on Therapeutic Drug Monitoring of Antiretroviral Agents2002/08/20English89
Identification of a Highly Divergent HIV Type 2 and Proposal for a Change in HIV Type 2 Classification2004/06/01English89